Your body is a sophisticated metabolic machine that can convert excess carbohydrates into stored fat through a process called de novo lipogenesis (DNL). While this pathway evolved as a survival mechanism, modern diets rich in ultra-processed foods (UPFs) and high-fructose corn syrup (HFCS) have turned DNL into a driver of obesity, insulin resistance, and metabolic disease.
Understanding DNL is essential for anyone seeking sustainable fat loss. Rather than obsessing over the outdated CICO (Calories In, Calories Out) model, we must examine how food quality, hormonal signaling, and timing influence whether incoming carbs are burned for energy or stored as fat.
What Is De Novo Lipogenesis and When Does It Activate?
De novo lipogenesis is the biochemical pathway in which the liver converts excess glucose and fructose into fatty acids and triglycerides. Under normal conditions, DNL is minimal because the body prefers to burn carbohydrates directly or store them as glycogen. However, when glycogen stores are full and carbohydrate intake remains chronically high, the surplus is shunted into fat synthesis.
Fructose is particularly potent at stimulating DNL. Unlike glucose, which can be used by nearly every cell, fructose is almost entirely metabolized in the liver. High intake of HFCS and refined sugars floods this pathway, leading to increased production of palmitate and other saturated fats. These lipids can then be packaged into VLDL particles or stored as liver fat, setting the stage for non-alcoholic fatty liver disease.
Clinical markers reveal when DNL is overactive. Elevated HOMA-IR, rising A1C, and increased inflammatory markers such as C-Reactive Protein (CRP) often accompany heightened DNL. Monitoring these helps track whether dietary changes are successfully reducing the body’s reliance on turning carbs into fat.
The Hormonal Hijack: Insulin, Leptin, and Adipose Tissue Signaling
Chronic carbohydrate overload keeps insulin elevated, which directly activates the enzymes responsible for DNL. At the same time, high-sugar diets impair leptin sensitivity. Leptin is the hormone produced by adipose tissue that signals the brain to stop eating when energy stores are sufficient. When leptin sensitivity is lost, the brain believes the body is starving despite abundant fat stores, driving further overconsumption.
Adipose tissue signaling becomes dysregulated as visceral fat expands. Inflamed fat cells release pro-inflammatory cytokines that worsen systemic inflammation and further blunt satiety signals. This creates a vicious cycle where DNL accelerates, fat storage increases, and metabolic flexibility declines.
Emerging therapies that target incretin hormones show promise in interrupting this cycle. GLP-1 and GIP play critical roles in glucose homeostasis, slowing gastric emptying, enhancing insulin secretion, and reducing appetite. By improving these hormonal pathways, the drive toward excessive DNL can be diminished while restoring proper adipose tissue signaling.